Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Rheumatoid Arthritis Q&As

Lars Klareskog, MD
Q&A
Lars Klareskog, MD, on the Study of Occupational Exposures and Risk of RA
08/08/2023
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a...
08/08/2023
Rheumatology & Arthritis
Q&As
4 Questions About Inhibitor of DNA Binding 1 Protein in Rheumatoid Arthritis
11/27/2019
Inhibitor of DNA binding 1 (ID-1) is a nuclear transcription factor that controls transcriptional activation of target genes. Previous research indicates that ID-1 may contribute to angiogenesis and vasculogenesis...
Inhibitor of DNA binding 1 (ID-1) is a nuclear transcription factor that controls transcriptional activation of target genes. Previous research indicates that ID-1 may contribute to angiogenesis and vasculogenesis...
...
11/27/2019
Rheumatology & Arthritis
Q&As
4 Questions About Methotrexate-Based Treatment Strategies in Early RA
10/02/2019
Methotrexate (MTX) has remained an integral part of the management of rheumatoid arthritis (RA) and other rheumatic conditions over time, despite numerous therapeutic advances. Still, studies that describe real-world...
Methotrexate (MTX) has remained an integral part of the management of rheumatoid arthritis (RA) and other rheumatic conditions over time, despite numerous therapeutic advances. Still, studies that describe real-world...
...
10/02/2019
Rheumatology & Arthritis

Advertisement

Q&As
5 Questions About Anti-MAA Antibodies in RA-Associated Interstitial Lung Disease
09/06/2019
Individuals with rheumatoid arthritis (RA) have an increased risk of premature mortality. Those with RA-associated interstitial lung disease (RA-ILD) have an even greater risk, with a median survival of 3 years after...
Individuals with rheumatoid arthritis (RA) have an increased risk of premature mortality. Those with RA-associated interstitial lung disease (RA-ILD) have an even greater risk, with a median survival of 3 years after...
...
09/06/2019
Rheumatology & Arthritis
Q&As
4 Questions About RAPID3 for RA
09/03/2019
Previous studies have suggested routine assessment of patient index data 3 (RAPID3) is reliable and convenient for monitoring disease activity in rheumatoid arthritis (RA). A prospective study led by Michael Ward, MD,...
Previous studies have suggested routine assessment of patient index data 3 (RAPID3) is reliable and convenient for monitoring disease activity in rheumatoid arthritis (RA). A prospective study led by Michael Ward, MD,...
Previous...
09/03/2019
Rheumatology & Arthritis
Q&As
5 Questions About Asthma and Rheumatoid Arthritis
06/27/2019
It has been thought that rheumatoid arthritis (RA) originates at mucosal surfaces, particularly in the airway mucosa. To determine whether this hypothesis is correct, researchers led by Vanessa Kronzer, MD, who is...
It has been thought that rheumatoid arthritis (RA) originates at mucosal surfaces, particularly in the airway mucosa. To determine whether this hypothesis is correct, researchers led by Vanessa Kronzer, MD, who is...
It has...
06/27/2019
Rheumatology & Arthritis

Advertisement

Q&As
5 Questions About DMARDs in RA
04/18/2019
Methotrexate is recommended as initial treatment for patients with rheumatoid arthritis (RA). However, treatment strategies can be altered if methotrexate does not meet treatment targets. Available data on the...
Methotrexate is recommended as initial treatment for patients with rheumatoid arthritis (RA). However, treatment strategies can be altered if methotrexate does not meet treatment targets. Available data on the...
...
04/18/2019
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay in the Know

Rheumatology & Arthritis Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Telehealth Answers Patients' Needs and Allays Fears During Pandemic
Conference Coverage
Telehealth Answers Patients' Needs and Allays Fears During Pandemic
07/14/2020
In the final session of the virtual Interdisciplinary Autoimmune Summit, Joseph Merola, MD, and Alice Gottlieb, MD, spoke about how telehealth can benefit patients and physicians, and how to use it to assist in diagnosing psoriatic arthritis.
In the final session of the virtual Interdisciplinary Autoimmune Summit, Joseph Merola, MD, and Alice Gottlieb, MD, spoke about how telehealth can benefit patients and physicians, and how to use it to assist in diagnosing psoriatic arthritis.
In the final session of the...
07/14/2020
Rheumatology & Arthritis
News
Toxicity May Outweigh Treatment Benefit of IV Steroids in GCA
04/07/2021
Researchers reveal that the benefit of intravenous glucocorticoid treatment in patients with giant cell arteritis may not be significant enough to risk exposure to the drugs’ toxicity.
Researchers reveal that the benefit of intravenous glucocorticoid treatment in patients with giant cell arteritis may not be significant enough to risk exposure to the drugs’ toxicity.
Researchers reveal that the...
04/07/2021
Rheumatology & Arthritis
Expert Conversations: Fabian Sandoval, MD, and Gustavo Corrales, MD, on Latinx Clinical Research Inclusion
Published in Partnership
Expert Conversations: Fabian Sandoval, MD, and Gustavo Corrales, MD, on Latinx Clinical Research Inclusion
01/25/2021
Bringing clinical research to Latinx communities has become a joint mission for these podcast guests, Fabian Sandoval, MD, and Gustavo Corrales, MD. New US Food and Drug Administration mandates require clinical trial...
Bringing clinical research to Latinx communities has become a joint mission for these podcast guests, Fabian Sandoval, MD, and Gustavo Corrales, MD. New US Food and Drug Administration mandates require clinical trial...
Bringing clinical research to...
01/25/2021
Rheumatology & Arthritis
How Common Is Diagnostic Delay in PsA?
How Common Is Diagnostic Delay in PsA?
11/13/2020
This information is brought to you by Rheumatology Consultant and is not sponsored by, nor a part of, the American College of Rheumatology. It is not uncommon for patients with psoriatic arthritis (PsA) to have a...
This information is brought to you by Rheumatology Consultant and is not sponsored by, nor a part of, the American College of Rheumatology. It is not uncommon for patients with psoriatic arthritis (PsA) to have a...
This...
11/13/2020
Rheumatology & Arthritis
After Hip or Pelvic Fracture, Cognitive Behavioral Intervention May Be Key
After Hip or Pelvic Fracture, Cognitive Behavioral Intervention May Be Key
09/09/2020
Older adults who are recovering from a hip or pelvic fracture may experience more positive outcomes if their rehabilitation includes a cognitive behavioral intervention, according to findings of a new study. This...
Older adults who are recovering from a hip or pelvic fracture may experience more positive outcomes if their rehabilitation includes a cognitive behavioral intervention, according to findings of a new study. This...
Older...
09/09/2020
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use